Home
Conditions
Sleep Wake Disorders

Clinical trial condition

Sleep Wake Disorders

Explore clinical trials studying Sleep Wake Disorders. Study availability and eligibility vary by location and protocol.

5,016 public trials 762 recruiting studies

Refine in advanced search Browse all conditions

Sleep Wake Disorders trial results

Completed

Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life

NCT00539461

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Boehringer Ingelheim Investigational Site Aalen, Germany

Boehringer Ingelheim Investigational Site Aarbergen, Germany

Boehringer Ingelheim Investigational Site Adendorf, Germany

Boehringer Ingelheim Investigational Site Aham, Germany

View all 317 locations

View Trial Details

Completed

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

NCT00275457

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Univ.-Klinik für Neurologie Graz, Austria

Univ.-Klinik für Neurologie Innsbruck, Austria

AKH der Stadt Linz Linz, Austria

Confraternität Privatklinik Vienna, Austria

View all 34 locations

View Trial Details

Completed

Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome

NCT00152997

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Boehringer Ingelheim Investigational Site Akita, Akita, Japan

Boehringer Ingelheim Investigational Site Kochi, Kochi, Japan

Boehringer Ingelheim Investigational Site Kurume, Fukuoka, Japan

Boehringer Ingelheim Investigational Site Otaru,Hokkaido, Japan

View Trial Details

Completed

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

NCT00375284

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: 248.616.065 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

248.616.028 Boehringer Ingelheim Investigational Site Dothan, Alabama, United States

248.616.035 Boehringer Ingelheim Investigational Site Mesa, Arizona, United States

248.616.025 Boehringer Ingelheim Investigational Site Peoria, Arizona, United States

View all 52 locations

View Trial Details

Completed

The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea

NCT00701441

Conditions: Apnea, Dyssomnias, Nervous System Diseases, +6 more
Locations: The Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea

NCT00936481

Conditions: Apnea, Dyssomnias, Nervous System Diseases, +7 more
Locations: Vanderbilt University Medical Center,Department of Neurology Nashville, Tennessee, United States

View Trial Details

Completed

Restless Legs Syndrome in Stroke Patients

NCT01967303

Conditions: Brain Diseases, Brain Ischemia, Cardiovascular Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Education Programme on Continuous Positive Airway Pressure Treatment

NCT01173406

Conditions: Apnea, Dyssomnias, Nervous System Diseases, +7 more
Locations: Queen Mary Hospital Hong Kong Island, Hong Kong

View Trial Details

Completed

Long Term Efficacy of Education Programme on Continuous Positive Airway Pressure Treatment

NCT01428921

Conditions: Apnea, Dyssomnias, Nervous System Diseases, +6 more
Locations: Queen Mary Hospital Hong Kong

View Trial Details

Completed

Obstructive Sleep Apnea and Diabetes Mellitus

NCT00876980

Conditions: Apnea, Diabetes Mellitus, Diabetes Mellitus, Type 2, +13 more
Locations: Queen Mary Hospital, University Department of Medicine Pokfulam, Hong Kong

View Trial Details

Sleep Wake Disorders

Sleep Wake Disorders trial results

Related conditions